Where can a licensed med spa source peptide products?
It depends on what the product is. FDA-approved finished medications are purchased through licensed wholesale distribution channels. Compounded drugs come from a state-licensed 503A pharmacy (generally for an identified patient with a prescription) or an FDA-registered 503B outsourcing facility (which may supply healthcare facilities for office use). Bulk pharmaceutical ingredients are raw materials intended for pharmacies, outsourcing facilities and manufacturers, not for clinics to administer. A med spa should confirm which category a product falls into and what its state requires before choosing a source. Tribal RX reviews each business account and discusses product eligibility before providing pricing.
Source: FDA: Compounding and the FDA — Questions and Answers
How should a clinic verify a peptide supplier?
Ask the supplier to explain its role (manufacturer, distributor, pharmacy or outsourcing facility) and verify any licenses or registrations directly with the issuing state board or FDA database. Request lot-specific Certificates of Analysis and check that lot numbers match the product received. Ask how products are traced back to their manufacturer, how they are stored and shipped, and whether the supplier verifies its buyers. Be cautious of suppliers that sell to anyone without review or that make treatment claims.
What determines whether a peptide product can legally be supplied or used?
Key factors include whether the product is an FDA-approved drug, a compounded drug or a bulk ingredient; whether a bulk substance meets the federal criteria for use in 503A or 503B compounding; whether the product is regulated as a biological product, which generally cannot be compounded under sections 503A or 503B; the buyer's license and facility type; whether a prescription is required; and state law. Products sold as 'research use only' are not intended for human use. Because these rules change and vary by state, confirm specific products with your regulatory counsel or state board of pharmacy.
Source: FDA: FD&C Act provisions that apply to human drug compounding; FDA: Compounding Q&A
What is the difference between 503A and 503B compounding?
Section 503A covers compounding by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician, based on a valid prescription for an identified individual patient. 503A pharmacies are primarily overseen by state boards of pharmacy and are not required to follow federal current good manufacturing practice (CGMP). Section 503B covers outsourcing facilities that register with FDA, must comply with CGMP, are subject to FDA inspection on a risk-based schedule, and may compound with or without patient-specific prescriptions, including for office use by healthcare facilities. Compounded drugs from either source are not FDA-approved.
Source: FDA: Compounding Q&A
When is a patient-specific prescription required?
Under federal law, drugs compounded under section 503A must be based on a valid prescription for an identified individual patient; limited quantities may be compounded in advance of a prescription based on an established history of orders. FDA's position is that 503A does not allow distribution for general office stock. A clinic that needs compounded drugs for office use generally sources them from a 503B outsourcing facility. Some states have their own office-use rules, so confirm your state's requirements. FDA-approved prescription drugs still require a prescription or practitioner order under applicable law.
Source: FDA: FD&C Act provisions that apply to human drug compounding
What does a certificate of analysis establish, and what does it not establish?
A certificate of analysis (COA) reports the results of specified tests, such as identity, purity or assay, performed on one specific lot against stated specifications, and identifies who performed the testing. It does not establish FDA approval, that a substance may legally be compounded or administered, that the product is safe or effective for any use, or that other lots will have the same results. Check that the lot number matches your product and that the testing laboratory and methods are identified.
What information is needed to open a Tribal RX business account?
Start with your business name, contact name, work email, phone, business type, state and product interest. During review we may request license numbers, facility type (for example 503A or 503B status), the prescribing or supervising professional, intended professional use and shipping destination.
How can a clinic request pricing and sourcing documentation?
Submit the 'Request Clinic Pricing & Sourcing Information' form on this page and list the products and documents you need. The Tribal RX business development team responds to complete inquiries within a few hours. Pricing and available documentation (such as COAs, batch documentation and traceability records, which vary by product and lot) are shared after account approval.
Regulations and FDA guidance change, and state rules differ. Confirm specific products and office-use questions with your regulatory counsel or state board of pharmacy. See also Quality & Sourcing.
